GSTM1 and bone metastasis: All new and existing cases with ALP >236 U/L, CRP >84 μg/mL, Hb <10.5 g/L, and ESR >74 mm/AEFH require intensive monitoring for the possible occurrence of bone metastasis and concomitant SREs.